On November 14, 2023, MedX Health Corp closed the transaction. The company issued 14,571,428 units for gross proceeds of CAD 1,020,000. Each unit is exercisable to purchase one common share exercisable for a period commencing on the date of issue and expiring on December 31, 2026. The transaction included participation from insiders for CAD 630,000. The transaction included participation from six investors including three insiders for 9,000,000 units.

On November 17, 2023, the company announced that the transaction has been approved by the TSX Venture Exchange.